Cannabis Science Inc  

(Public, OTCMKTS:CBIS)   Watch this stock  
Find more results for PINK:CBIS
0.0574
+0.0018 (3.24%)
Dec 18 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.05 - 0.06
52 week 0.03 - 0.30
Open 0.06
Vol / Avg. 3.71M/4.14M
Mkt cap 53.66M
P/E     -
Div/yield     -
EPS -0.01
Shares 934.92M
Beta 2.32
Inst. own 0%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin - -7189.60%
Operating margin - -6870.12%
EBITD margin - -3942.48%
Return on average assets -230.42% -704.41%
Return on average equity - -
Employees 5 -
CDP Score - -

Address

Suite B #254, 6946 North Academy Blvd
COLORADO SPRINGS, CO 80918
United States - Map
+1-888-8890888 (Phone)

Description

Cannabis Science, Inc. is a development-stage company. Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. The Company is dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance. The Company is engaged in medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. Effective August 25, 2014, Cannabis Science Inc acquired an undisclosed pharmaceutical co, located in British Columbia.

Officers and directors

Raymond C. Dabney President, Chief Executive Officer, Co-Founder, Director
Chad S. Johnson Esq. General Legal Counsel, Corporate Secretary, Director
Age: 46
Mario Lap Director